Therap adv gastroenterol影响因子
WebbScope Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. Webb29. Kaffes A, Corte C. Fine needle aspiration at endoscopic ultrasound with a novel side-port needle: a pilot experience. Therap Adv Gastroenterol. 2012 Mar;5(2):89-94. 30. Kaffes AJ. Advances in modern enteroscopy therapeutics. Best Pract Res Clin Gastroenterol. 2012 Jun;26(3):235-46. 31. Chua TJ, Kaffes AJ.
Therap adv gastroenterol影响因子
Did you know?
WebbTherap Adv Gastroenterol：益生菌治疗脂肪肝，值得探索——系统评价和荟萃分析 2024-10-23 国际肝病编辑部 国际 国际肝病 益生菌 非酒精性脂肪肝 肝功能 在最近几十年中，非酒 … WebbTherapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders.
Webb5 sep. 2015 · Regorafenib has been approved by the US Food and Drug Administration (FDA) for the treatment of metastatic colorectal cancer (mCRC) in patients who have failed treatment with fluoropyrimidine, oxaliplatin and irinotecan based chemotherapy, an anti-VEGF therapy and, if KRAS wild type, an anti-EGFR therapy. Webb阅读量：. 36. 作者：. pubmeddev. 摘要：. PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. …
Webb23 dec. 2024 · Tofacitinib is a safe and effective therapy in real-world UC patients, as previously reported by clinical trials. Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis Therap Adv Gastroenterol. 2024 Dec 23;14:17562848211064004.doi: 10.1177/17562848211064004. eCollection 2024. Authors WebbTitle Abbreviation: Therap Adv Gastroenterol Title(s): Therapeutic advances in gastroenterology. Publication Start Year: 2008 Publication End Year: Frequency: …
WebbTherapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders.
Webb27 maj 2024 · The impact score (IS) 2024 of Therapeutic Advances in Gastroenterology is 4.52, which is computed in 2024 as per its definition. Therapeutic Advances in … porsche for sale trinidadWebb12 nov. 2014 · Therap Adv Gastroenterol. 2011;4(3):185-197. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol. 1999;65(11):4949-4956. McFarland … porsche for sale tucsonWebb5 sep. 2015 · Regorafenib has been approved by the US Food and Drug Administration (FDA) for the treatment of metastatic colorectal cancer (mCRC) in patients who have … porsche for sale used cheapWebbTherapeutic Advances in Gastroenterology杂志网站提供THER ADV GASTROENTER期刊影响因子、JCR和中科院分区查询，SCI期刊投稿经验，Impact Factor ... iris technologies eoodWebb27 maj 2024 · The impact score (IS) 2024 of Therapeutic Advances in Gastroenterology is 4.52, which is computed in 2024 as per its definition. Therapeutic Advances in Gastroenterology IS is increased by a factor of 0.56 and approximate percentage change is 14.14% when compared to preceding year 2024, which shows a rising trend. porsche for sale usedWebbTherapeutic Advances in GastroenterologySCImago SJR Rank. SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts … porsche formel e wallpaperWebb10 dec. 2024 · Year 2024. PubMed DOI Crossref. Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective … iris technical communication